176 related articles for article (PubMed ID: 7004797)
21. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
[TBL] [Abstract][Full Text] [Related]
22. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
Renard M; Jacobs P; Liebens I; Abou Hamdam B; Bernard R
Int J Cardiol; 1986 Feb; 10(2):149-58. PubMed ID: 3080379
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of I.V. labetalol for treatment of posttraumatic hyperdynamic state.
Morel DR; Forster A; Suter PM
Intensive Care Med; 1984; 10(3):133-7. PubMed ID: 6736412
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H
Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764
[TBL] [Abstract][Full Text] [Related]
26. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
Feldman RL; Prida XE; Hill JA
Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
[TBL] [Abstract][Full Text] [Related]
27. Effects of the automated management of hypertension after open heart surgery. The relevance of the initial systemic vascular resistance as index for predicting hemodynamic response to computer-controlled nitroprusside infusion.
Pomer S; Elert O; Satter P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):207-13. PubMed ID: 6715091
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
Koch G
Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
[TBL] [Abstract][Full Text] [Related]
29. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
Joekes AM; Thompson FD
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
[TBL] [Abstract][Full Text] [Related]
30. Intravenous labetalol in hypertensive patients given by fast and slow injection.
Pearson RM; Havard CW
Br J Clin Pharmacol; 1978 May; 5(5):401-5. PubMed ID: 350248
[TBL] [Abstract][Full Text] [Related]
31. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
32. Labetalol infusion in hypertensive emergencies.
Lebel M; Langlois S; Belleau LJ; Grose JH
Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
[TBL] [Abstract][Full Text] [Related]
33. Continuous i.v. infusion of labetalol for postoperative hypertension. Haemodynamic effects and plasma kinetics.
Chauvin M; Deriaz H; Viars P
Br J Anaesth; 1987 Oct; 59(10):1250-6. PubMed ID: 3676053
[TBL] [Abstract][Full Text] [Related]
34. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular effects of glucagon following cardiac surgery.
Vaughn CC; Warner HR; Nelson RM
Surgery; 1970 Jan; 67(1):204-11. PubMed ID: 5409857
[No Abstract] [Full Text] [Related]
36. Intravenous labetalol in the emergency treatment of hypertension.
Vidt DG
J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
[TBL] [Abstract][Full Text] [Related]
37. Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.
Lund-Johansen P
Am J Med; 1983 Oct; 75(4A):24-31. PubMed ID: 6638038
[TBL] [Abstract][Full Text] [Related]
38. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
39. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
[TBL] [Abstract][Full Text] [Related]
40. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
